Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
CVKD on Nasdaq
Shares outstanding
1,783,394
Price per share
$6.91
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
114,193
Total reported value
$1,573,701
% of total 13F portfolios
0%
Share change
+45,846
Value change
+$635,888
Number of holders
17
Price from insider filings
$6.91
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Pham Quang X 24% $7,115,610 421,042 Quang X. Pham 23 Jan 2025
Havlickova 648 a.s. 4.4% $1,323,118 78,291 Havlickova 648 a.s. 31 Dec 2024
MURPHY JOHN RAYMOND 3% $899,164 53,205 John Raymond Murphy 31 Dec 2024

As of 30 Sep 2025, 17 institutional investors reported holding 114,193 shares of Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD). This represents 6.4% of the company’s total 1,783,394 outstanding shares.

Institutional Holders of Cadrenal Therapeutics, Inc. - Common Stock, par value $0.001 per share (CVKD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 114,193 $1,573,701 +$635,888 $13.83 17
2025 Q2 68,347 $823,305 -$12,430 $12.05 14
2025 Q1 69,304 $1,221,972 +$961,600 $17.63 13
2024 Q4 14,845 $215,103 +$214,451 $14.49 9
2024 Q3 5 $68 +$68 $13.60 1